https://www.biopharmadive.com/news/roche-abbvie-venclexta-acute-myeloid-leukemia/574680/
Leukemia drug from Roche, AbbVie extends survival, study finds | BioPharma Dive
Paired with chemotherapy, Venclexta succeeded in a Phase 3 acute myeloid leukemia trial just weeks after falling short in another combination study.
leukemia drugextends survival
https://www.sciencealert.com/breakthrough-breast-cancer-pill-extends-survival-in-7-year-trial
Breakthrough Breast Cancer Pill Extends Survival in 7-Year Trial : ScienceAlert
Aug 31, 2025 - A breakthrough therapy for advanced breast cancer also works well in the early stages, allegedly improving survival outcomes for patients.
breast cancerextends survival